Insulet Corporation (PODD)

Insulet Revenue

Insulet had revenue of $842.00M in the quarter ending September 30, 2026, with 19.21% growth. This brings the company's total for the last twelve months to $3.19B, up 26.46% year-over-year. In the year 2025, Insulet had annual revenue of $2.71B with 30.73% growth. That makes Insulet the 3,664th largest company in the world by revenue and 1,016th in the United States.

• Revenue (ttm): $3.19B
• Revenue Growth: +26.46%
• P/S Ratio: 3.19
• Revenue / Employee: $590,593
• Employees: 5,400
• Market Cap: 10.16B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• US Omnipod 1.92B 70.9%
• International Omnipod 754.30M 27.9%
• Drug Delivery 34.10M 1.3%

By Geography

Chart

• United States 1.95B 72.1%
• International 754.30M 27.9%

Fiscal year ended Dec 31, 2025 See the full Insulet breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.71B	636.50M	30.73%
Dec 31, 2024	2.07B	374.50M	22.07%
Dec 31, 2023	1.70B	391.80M	30.02%
Dec 31, 2022	1.31B	206.50M	18.79%
Dec 31, 2021	1.10B	194.40M	21.49%
Dec 31, 2020	904.40M	166.20M	22.51%
Dec 31, 2019	738.20M	174.40M	30.93%
Dec 31, 2018	563.80M	100.00M	21.56%
Dec 31, 2017	463.80M	96.81M	26.38%
Dec 31, 2016	366.99M	103.10M	39.07%
Dec 31, 2015	263.89M	32.57M	14.08%
Dec 31, 2014	231.32M	-15.76M	-6.38%
Dec 31, 2013	247.08M	35.72M	16.90%
Dec 31, 2012	211.37M	59.11M	38.83%
Dec 31, 2011	152.26M	55.29M	57.02%
Dec 31, 2010	96.97M	30.93M	46.85%
Dec 31, 2009	66.03M	29.97M	83.12%
Dec 31, 2008	36.06M	22.69M	169.66%
Dec 31, 2007	13.37M	9.71M	265.06%
Dec 31, 2006	3.66M	3.61M	7,226.00%
Dec 31, 2005	50.00K	-	-

Data Source: Fiscal.ai Last updated: Nov 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error